Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Jan 22, 2021
Three Major Defense Companies Set to Report Earnings and Rated as Buys

Three Major Defense Companies Set to Report Earnings and Rated as Buys

With earnings season starting to heat up, we will see certain industries grouped together with their earnings reports. The week of January 25 through 29 is a big one for defense companies. There are at least 10 companies set to report their latest earnings results, but I want to focus on three in particular.

Lockheed Martin (LMT) will report on Tuesday, January 26. General Dynamics (GD) is set to report fourth quarter results on Wednesday, January 27. Northrop Grumman (NOC) will release its fourth quarter results on Thursday, January 28.

All three companies have “buy” ratings on the Tickeron scorecards and all three are expected to see earnings growth compared to last year and compared to last quarter. The following table shows the EPS estimate for the fourth quarter and how it compares to the third quarter as well as how it compares to Q4 2019.

As you can see, Lockheed is expected to see a pretty big jump on a year over year basis while General Dynamics is expected to see a big jump on a quarter over quarter basis. Northrop’s growth expectations are much more modest.

If we look at the fundamental analysis for the three stocks, Lockheed gets three positive ratings and only one negative rating. Northrop shows two positive ratings and no negative ratings. General Dynamics doesn’t fare as well with only one positive rating and three negative ratings. The one category where all three companies score well is in the Valuation Ratings. Both General Dynamics and Lockheed score poorly in the P/E Growth Ratings.

All three companies score well on the technical screener. Lockheed has four bullish signals and no bearish signals. Northrop has four bullish signals and one bearish signal. General Dynamics has three bullish signals and no bearish signals. The one indicator that has flashed a bullish signal for all three stocks is the MACD.

One aspect of investing in defense industry stocks is dealing with the political influences. The defense industry is an area that seems to be misunderstood when it comes to performance and how politics impacts it. A common believe is that the industry does better under Republican administrations and doesn’t do as well under Democratic administrations. While it’s true that Republican administrations tend to favor larger defense budgets compared to Democrats, the stock performances of the industry don’t necessarily correlate.

All three of the stocks included in this analysis moved higher during the Bush presidency and they outperformed the overall market. The three did even better and outperformed the market by a greater margin during the Obama presidency. All three stocks underperformed the market over the last four years. The point being that you shouldn’t invest based on misconceptions. It’s much better to use back-tested and statistical based analysis.

The complete analysis from Tickeron for these three companies appears below.


Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


Interact to see
Advertisement
During the week of 9–15 February 2026, major U.S. equity indices finished lower overall, while Tickeron’s trending AI trading bots produced positive returns, particularly in defense and energy—two areas now directly affected by the newly opened war in Iran. With macro risk rising and volatility picking up, this divergence matters: it shows how sector‑focused, rules‑based AI strategies can still find upside when broad index exposure is negative.
MRNA surged approximately +16.07% on March 4, 2026, closing at $57.84, up from the prior session's close of $49.83. The primary catalyst was Moderna's announcement of a landmark settlement in its long-running patent dispute over lipid nanoparticle (LNP) technology used in its mRNA vaccines.
Shares of The Trade Desk (TTD) surged +28.05% on March 5, 2026, reaching $32.23 from a prior close of $25.17. The primary catalyst was CEO Jeff Green's record insider purchase of approximately 6 million shares worth ~$148 million — the largest insider buy in the company's history.
AEO shares are trading at $19.89, down $2.56 or -11.40% from the prior session's close of $22.45. The primary catalyst is deeply disappointing Q1 fiscal 2026 operating income guidance of just $20–$25 million, which badly missed analyst expectations.
CIEN shares plunged 14.25% on March 5, 2026, trading at $294.59 versus the prior session's close of $343.55 — a decline of $48.96 per share. The steep sell-off came despite a strong earnings beat: adjusted EPS of $1.35 crushed the consensus estimate of $1.05 by 28.6%, and revenue of $1.43 billion rose 33% year-over-year.
Shares of Victoria's Secret & Co. (VSCO) tumbled approximately 11.87% in early trading on March 5, falling from a prior close of $60.01 to an intraday price near $52.89, with an intraday low of $51.61. The steep decline came despite a Q4 2025 earnings beat, with adjusted EPS of $2.77 topping the consensus estimate of $2.46 and revenue of $2.27 billion exceeding the expected $2.22 billion.
AMPX shares surged +18.57% in today's session, trading at $14.88 versus the prior close of $12.55. Primary catalyst: Q4 and full-year fiscal 2025 earnings, reported before the open, delivered a decisive beat on both EPS and revenue expectations.
EXPE shares are trading up approximately +9.70% intraday on March 5, 2026, rising from a prior close of $221.25 to around $242.71. March 5 is the stock's ex-dividend date for a newly raised quarterly dividend of $0.48 per share — a 20% increase from the prior payout — signaling strong management confidence in cash generation.
SES shares are down approximately 30% intraday on Thursday, March 5, 2026, trading near $1.19 against the prior session's close of $1.71. The primary catalyst is deeply disappointing 2026 revenue guidance of $30–$35 million — roughly 41% below the Wall Street consensus of $51.67 million.
What if a single trading robot could harvest volatility across semiconductors, oil, and communication technology — simultaneously — while filtering out the noise that burns most active traders? That's exactly what the Semiconductors, Oil & Energy, Communication Tech AI Trading Agent delivers. Over the past 364 days (March 5, 2025 – March 4, 2026), this agent generated a Total Net Profit of $20,641.78 on $500-per-trade sizing — an eye-catching Annualized Return of 68.58%. With 1,534 closed trades, a 61.86% win rate, and a dominant Profit Factor of 3.02
What if an AI trading agent could turn market chaos into a 45.55% annualized return? That's exactly what Tickeron's HUBB, AVGO, ITA, QQQ – AI Trading Agent (4 Tickers, 5min) has delivered across 106 days of live trading — posting $11,605.87 in total net profit from a per-trade allocation of $2,500–$8,250, a 69.59% win rate across 444 closed trades, and a Profit Factor of 2.18.
83.97% Win Rate | 87.10% Annualized Return | $44,879.15 Total Net Profit | Profit Factor: 4.92 | Sharpe Ratio: 1.13
HYMC’s latest sell‑off is part of a broader downtrend that accelerated after the company delayed its PEA, which investors interpreted as an uncertainty event despite no immediate change in reported resources or cash position. Technical indicators such as HYMC breaking above its upper Bollinger Band and then rolling over, along with the Aroon indicator turning down in late February, signaled an elevated risk of a sharp pullback that is now playing out.
DSGR reported quarterly EPS of about 0.18 dollars, badly missing consensus estimates of roughly 0.32–0.33 dollars per share and marking a sharp drop from 0.42 dollars a year ago, which triggered a large negative earnings surprise. Revenue of about 481–482 million dollars came in below expectations near 496 million dollars, and adjusted EBITDA margins compressed to about 7.4% from 9.3% in the prior‑year quarter, highlighting cost and mix pressures.
Shares of CRDO surged +11.90% on March 5, 2026, closing at $114.74 versus a prior close of $102.54. Primary catalyst: Strong Q3 fiscal 2026 earnings reported on March 2, with revenue of $407 million beating consensus estimates by more than $19 million and non-GAAP EPS of $1.07 surpassing forecasts by $0.29.
SPY is trading down approximately -1.30% in Friday premarket, slipping from the prior session's close of $681.31 to around $677–$678. The primary catalyst is a sharply negative February 2026 Nonfarm Payrolls report, which showed a decline of 92,000 jobs — a massive miss versus the consensus forecast of +50,000.
WAL shares dropped approximately 12% in early trading on March 6, 2026, from a prior close of ~$80.74 to roughly ~$71, marking one of the stock's sharpest single-session declines in recent months. The primary catalyst was a surprise announcement that Jefferies Financial Group declined to make a $126.4 million payment owed to Western Alliance Bank under a forbearance agreement tied to the LAM Trade Finance loan portfolio.
MRVL shares surged approximately +15% at the open on March 6, 2026, after closing at $75.68 the prior session. The primary catalyst was a strong Q4 fiscal 2026 earnings report released after the close on March 5, with non-GAAP EPS of $0.80 beating the $0.79 consensus estimate and revenue of $2.219 billion exceeding expectations.
Shares of Day One Biopharmaceuticals surged approximately +65.57% on March 6, 2026, rising from a prior close of $12.78 to an intraday price around $21.16. The primary catalyst driving the session's gains is acquisition and takeover speculation, with reports circulating that Day One may be a buyout target.
GAP shares fell approximately 13% in early trading on March 6, 2026, following the company's Q4 fiscal 2025 earnings report released after market close on March 5. Gap met Wall Street's Q4 estimates on both earnings per share and revenue, but fiscal 2026 guidance fell short of analyst expectations.